Zacks Investment Management Amneal Pharmaceuticals, Inc. Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.74 - $7.38 $75,057 - $116,862	-15,835 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $426,366 - $585,040	-107,941 Reduced 87.21%	15,835 $72,000
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $11,402 - $16,974	-3,221 Reduced 2.54%	123,776 $480,000
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $364,481 - $693,403	126,997 New	126,997 $605,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.